This study shows promising results for people with multiple sclerosis which is a very debilitating condition. However, it also holds promise for people with epilepsy. “Potentially there could be many drugs which are licensed for specific conditions but ...
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.